KNSA — KINIKSA PHARMACEUTICALS INTL

Ownership history in Caption Management, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in KINIKSA PHARMACEUTICALS INTL (KNSA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.42% (2025 Q4)
Avg. % of fund
0.11%
First filed
2024 Q2
Last filed
2025 Q4
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,490,500 +987,900 +196.6% 0.42% $61.5M $41.25
2025 Q3 ADDED 502,600 +412,600 +458.4% 0.15% $19.5M $38.83
2025 Q3 REDUCED 90,000 -140,000 -60.9% 0.03% $3.5M $38.83
2025 Q2 REDUCED 230,000 -912,500 -79.9% 0.07% $6.4M $27.67
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    KNSA price (monthly, adj. close)

Other funds also holding KNSA

As of 2025 Q4 — sorted by position size

TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.6% Fairmount Funds Management LLC 3Y 4.14% Parkman Healthcare Partners LLC 3Y 2.61% Rubric Capital Management LP 3Y 7Y 1.64% ESSEX INVESTMENT MANAGEMENT CO LLC 3Y 7Y 1.58% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 1.35% Soleus Capital Management, L.P. 3Y 0.89% Logos Global Management LP 3Y 0.87% BAKER BROS. ADVISORS LP 3Y 7Y 0.68% GLOBEFLEX CAPITAL L P 3Y 7Y 0.59%
← Back to Caption Management, LLC Holdings